DexCom(FRA) DC4

Market Cap€28.83B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€78.40

+0.26%

+0.20Today

DexCom Financials at a Glance

Market Cap

€28.83B

Revenue (TTM)

€4.26K

Net Income (TTM)

€857.27

EPS (TTM)

€2.17

P/E Ratio

35.17

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Price

€78.40

Volume

Open

€77.80

Price

€78.40

Volume

Open

€77.80

Previous Close

€78.40

Daily Range

€77.00 - €78.40

52-Week Range

€46.88 - €79.20

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

0.00 (Low)

Price

€78.40

Volume

Open

€77.80

Previous Close

€78.40

Daily Range

€77.00 - €78.40

52-Week Range

€46.88 - €79.20

Estimated Earnings Date

N/A

DC4 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About DexCom

DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

11,100

CEO

Jacob S. Leach

Website

www.dexcom.com

DC4 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

38.23%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

2.84%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€28.83B

Shares Outstanding

377.36M

Volume

Avg. Volume

77.803

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

DexCom Performance Analysis

DexCom annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 2,768,668,990	33.7%
2023	2023-12-31	EUR 3,350,520,509	21.0%
2024	2024-12-31	EUR 3,728,422,358	11.3%
2025	2025-12-31	EUR 4,130,862,204	10.8%

DexCom annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR 0.76	77.4%
2023	2023-12-31	EUR 1.20	58.6%
2024	2024-12-31	EUR 1.32	9.3%
2025	2025-12-31	EUR 1.85	40.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€1.13K

+1.1%

Gross Profit

€713.85

+1.2%

Gross Margin

63.44%

+1.1%

Market Cap

€28.83B

N/A

Market Cap/Employee

€2.06

N/A

Employees

11,100

N/A

Net Income

€214.24

+1.4%

EBITDA

€332.41

+1.4%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€2.19K

-31.2%

Total Debt

€1.22K

+0.6%

Accounts Receivable

€1.10K

+1.0%

Inventory

€635.35

+1.3%

Long Term Debt

€1.21K

+1.0%

Short Term Debt

€18.11

+0.0%

Return on Assets

14.42%

+1.7%

Return on Invested Capital

12.79%

+1.1%

Free Cash Flow

€161.06

+0.9%

Operating Cash Flow

€234.32

+0.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About DC4

What is the current price of DexCom?

DexCom is trading at €78.40 per share.

What is the 52-week range for DexCom?

Over the past 52 weeks, DexCom has traded between €46.88 and €79.20.

How much debt does DexCom have?

As of the most recent reporting period, DexCom reported total debt of €1.22B.

How much cash does DexCom have on hand?

DexCom reported €966.50M in cash and cash equivalents in its most recent financial results.

What is DexCom’s dividend yield?

DexCom does not currently have a dividend yield.

DexCom(FRA) DC4

DexCom Financials at a Glance

DC4 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About DexCom

DC4 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

DexCom Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DC4

What is the current price of DexCom?

What is the 52-week range for DexCom?

How much debt does DexCom have?

How much cash does DexCom have on hand?

What is DexCom’s dividend yield?

Premium Investing Services